BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36401746)

  • 1. Anti-glomerular basement membrane glomerulonephritis concurrent with membranous nephropathy and acute tubular interstitial nephritis in a lung cancer patient treated with pembrolizumab.
    Hoshina A; Endo S
    CEN Case Rep; 2023 May; 12(2):230-236. PubMed ID: 36401746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of Anti-Glomerular Basement Membrane Glomerulonephritis and Membranous Nephropathy in a Female Patient with Preserved Renal Function.
    Ogawara A; Harada M; Ichikawa T; Fujii K; Ehara T; Kobayashi M
    Tohoku J Exp Med; 2017 Dec; 243(4):335-341. PubMed ID: 29269610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nivolumab-induced membranous nephropathy in a patient with stage IV lung adenocarcinoma.
    Wakabayashi K; Yamamoto S; Hara S; Okawara M; Teramoto K; Ikeda N; Kusunoki Y; Takeji M
    CEN Case Rep; 2022 May; 11(2):171-176. PubMed ID: 34524642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma.
    Ratanasrimetha P; Reddy VD; Kala J; Tchakarov A; Glass WF; Msaouel P; Lin JS
    Front Immunol; 2022; 13():898811. PubMed ID: 35967405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent Anti-Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case Series.
    Ahmad SB; Santoriello D; Canetta P; Bomback AS; D'Agati VD; Markowitz G; Ahn W; Radhakrishnan J; Appel GB
    Am J Kidney Dis; 2021 Aug; 78(2):219-225.e1. PubMed ID: 33421452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience.
    Mamlouk O; Selamet U; Machado S; Abdelrahim M; Glass WF; Tchakarov A; Gaber L; Lahoti A; Workeneh B; Chen S; Lin J; Abdel-Wahab N; Tayar J; Lu H; Suarez-Almazor M; Tannir N; Yee C; Diab A; Abudayyeh A
    J Immunother Cancer; 2019 Jan; 7(1):2. PubMed ID: 30612580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent anti-glomerular basement membrane disease and membranous glomerulonephritis: a case report and literature review.
    Troxell ML; Saxena AB; Kambham N
    Clin Nephrol; 2006 Aug; 66(2):120-7. PubMed ID: 16939068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranous nephropathy with crescents: a series of 19 cases.
    Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD
    Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathological features of anti-glomerular basement membrane disease associated with membranous nephropathy: an observational study.
    Zhang S; Li C; Huang J; Zhou Y; Gao C; Sun M; Wang R; Chen B
    Ren Fail; 2022 Dec; 44(1):1904-1914. PubMed ID: 36351876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of IgG subclasses in a biopsy specimen showing membranous nephropathy with anti-glomerular basement membrane glomerulonephritis: an uncharacteristically good outcome with corticosteroid therapy.
    Hoshino J; Hara S; Ubara Y; Takaya H; Suwabe T; Sawa N; Tagami T; Katori H; Takemoto F; Hara S; Takaichi K
    Am J Kidney Dis; 2005 Apr; 45(4):e67-72. PubMed ID: 15806463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical anti-glomerular basement membrane glomerulonephritis in a patient with metastatic melanoma treated with mitogen-activated protein kinase and immune checkpoint inhibitors: a case report.
    Kyriazis P; Tiwary A; Freeman J; Landry D; Braden G
    J Med Case Rep; 2021 Apr; 15(1):186. PubMed ID: 33810799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report.
    El Yamani N; Cote G; Riopel J; Marcoux N; Mac-Way F; Philibert D; Agharazii M
    Kidney Med; 2023 Aug; 5(8):100682. PubMed ID: 37415622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report.
    Hultin S; Nahar K; Menzies AM; Long GV; Fernando SL; Atkinson V; Cebon J; Wong MG
    BMC Nephrol; 2020 Sep; 21(1):391. PubMed ID: 32894101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis.
    Mitarai Y; Nakashima K; Fukunaga S; Ishikawa N; Ito T; Tsubata Y; Isobe T
    Intern Med; 2022 Jul; 61(13):2013-2017. PubMed ID: 34840226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of antiglomerular basement membrane glomerulonephritis complicated by membranous nephropathy.
    Iguchi A; Ishikawa T; Yamazaki H; Sakamaki Y; Ito T; Watanabe Y; Saeki T; Ito Y; Imai N; Narita I
    CEN Case Rep; 2014 May; 3(1):94-99. PubMed ID: 28509257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranous nephropathy followed by anti-glomerular basement disease: A case report and review of clinical presentation and treatment.
    Speer C; Gaida MM; Waldherr R; Nusshag C; Kälble F; Zeier M
    SAGE Open Med Case Rep; 2018; 6():2050313X18807621. PubMed ID: 30364512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapidly progressive glomerulonephritis due to anti-glomerular basement membrane disease accompanied by IgA nephropathy: An unusual association.
    Annamalai I; Chandramohan G; Srinivasa Prasad ND; Fernando E; Sujith S
    Saudi J Kidney Dis Transpl; 2017; 28(6):1404-1407. PubMed ID: 29265054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy: a case report.
    Yang Z; Xu H; Gou S; Wu H; Hu Z
    BMC Nephrol; 2023 May; 24(1):145. PubMed ID: 37226096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lung squamous cell carcinoma-associated membranous nephropathy patient free of tumor and membranous nephropathy after the treatment of surgery and radiochemotherapy following pembrolizumab: A rare case report.
    Chen F; Du H; Fang S
    Medicine (Baltimore); 2023 Jan; 102(3):e32508. PubMed ID: 36701715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
    Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
    Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.